Rhone Ma Holdings BhdXKLS:5278 61 Current Ratio is 4.11 as of Mar. 2026, which is 11% below its 10-year median of 4.64. GuruFocus rates XKLS:5278 with a GF Score™ of 61/100 and a GF Value™ of RM0.80 (Modestly Undervalued). Among 997 Drug Manufacturers companies, Rhone Ma Holdings Bhd ranks better than 79.44% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Rhone Ma Holdings Bhd's current ratio for the quarter that ended in Mar. 2026 was 4.11.
Rhone Ma Holdings Bhd has a current ratio of 4.11. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Rhone Ma Holdings Bhd's Current Ratio or its related term are showing as below:
XKLS:5278'
s Current Ratio Range Over the Past 10 Years
Min: 3.04 Med: 4.64 Max: 8.58
Current: 4.11
During the past 13 years, Rhone Ma Holdings Bhd's highest Current Ratio was 8.58. The lowest was 3.04. And the median was 4.64.
XKLS:5278's Current Ratio is ranked better than 79.44% of 997
companies
in the Drug Manufacturers industry
Industry Median: 2
vs XKLS:5278: 4.11
Rhone Ma Holdings Bhd (XKLS:5278) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Rhone Ma Holdings Bhd Current Ratio Related Terms
Rhone Ma Holdings Bhd Current Ratio Historical Data
* Premium members only.
The historical data trend for Rhone Ma Holdings Bhd's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:5278 vs ZTS, UTHR, VTRS: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Rhone Ma Holdings Bhd's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhone Ma Holdings Bhd Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rhone Ma Holdings Bhd's Current Ratio distribution charts can be found below:
* The bar in red indicates where Rhone Ma Holdings Bhd's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rhone Ma Holdings Bhd (XKLS:5278) has a Current Ratio of 4.11 as of Mar. 2026. This is 11% below median its historical median of 4.64. Over the past decade, Rhone Ma Holdings Bhd's Current Ratio has ranged from 3.04 to 8.58. According to the industry distribution chart, Rhone Ma Holdings Bhd ranks #205 out of 997 companies in the Drug Manufacturers industry, placing it in the top 20.6%.
Is Rhone Ma Holdings Bhd's Current Ratio too high?
Rhone Ma Holdings Bhd's current Current Ratio of 4.11 is 11% below median its 10-year median of 4.64. Over the past 10 years, this metric has ranged from a low of 3.04 to a high of 8.58. The Drug Manufacturers industry median Current Ratio is 2.00. Rhone Ma Holdings Bhd's value of 4.11 is 105.5% above this industry median. Based on the distribution chart, Rhone Ma Holdings Bhd ranks #205 out of 997 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Rhone Ma Holdings Bhd has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rhone Ma Holdings Bhd's Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Rhone Ma Holdings Bhd ranks #205 out of 997 companies for Current Ratio. This places Rhone Ma Holdings Bhd in the top 21% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.00. Rhone Ma Holdings Bhd's value of 4.11 is 105.5% above this benchmark. Historically, Rhone Ma Holdings Bhd's own Current Ratio has ranged from 3.04 to 8.58 over the past decade. While the company's 10-year median is 4.64 vs. the industry median of 2.00, Rhone Ma Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhone Ma Holdings Bhd's current Current Ratio of 4.11 is 105.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhone Ma Holdings Bhd's current Current Ratio is 4.11, which is 11% below median its own 10-year median of 4.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhone Ma Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Rhone Ma Holdings Bhd (XKLS:5278) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.80, compared to a current price of RM0.69 — trading 13.8% below its estimated fair value. The current Current Ratio is 4.11, which is 11% below median its 10-year median of 4.64 and 105.5% above the Drug Manufacturers industry median of 2.00. Rhone Ma Holdings Bhd's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Rhone Ma Holdings Bhd (XKLS:5278), the current Current Ratio is 4.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhone Ma Holdings Bhd (XKLS:5278) Overvalued in 2026?
Based on GuruFocus' analysis, Rhone Ma Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.69 is trading 13.8% below its estimated GF Value™ of RM0.80.
GuruFocus considers Rhone Ma Holdings Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:5278:
Current Ratio: 4.11 (11% below median its 10-year median of 4.64)
GF Value™: RM0.80 vs. price of RM0.69 (13.8% below fair value)
Industry Position: 105.5% above the Drug Manufacturers median (#205 of 997)
No single metric tells the full story. See the XKLS:5278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhone Ma Holdings Bhd, along with its subsidiaries, is mainly involved in the provision of end-to-end animal health solutions. The Group provides veterinary consultation services, diagnostic laboratory analyses, R&D, and is engaged in the manufacturing and distribution of animal health products. Its reportable segments are: Animal health products and equipment, Food ingredients, and Others. The majority of its revenue is generated from the Animal health products and equipment segment, which is engaged in marketing, trading, distribution, and manufacturing of animal health products and equipment, such as pharmaceuticals, vaccines, feed additives, pesticides, and others. Geographically, the Group's operations are predominantly located in Malaysia.
61GF Score
Get the complete analysis for XKLS:5278
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5278 has been successfully added to your 
